Amgen (AMGN)
(Delayed Data from NSDQ)
$332.92 USD
+0.12 (0.04%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $333.58 +0.66 (0.20%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
Earnings News For AMGN
-
Amgen (AMGN) Up 5.8% Since Last Earnings Report: Can It Continue?
-
Amgen (AMGN) Stock Down Despite Q2 Earnings & Sales Beat
-
Amgen (AMGN) Q2 Earnings and Revenues Beat Estimates
-
Amgen: Q2 Earnings Snapshot
-
AMGEN REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS
-
Can Amgen (AMGN) Keep the Beat Streak Alive in Q2 Earnings?
-
Amgen (AMGN) Expected to Beat Earnings Estimates: Should You Buy?
-
Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update
-
Amgen: Q1 Earnings Snapshot
-
AMGEN REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
-
What's in the Cards for Amgen (AMGN) This Earnings Season?
-
Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for
-
Amgen (AMGN) Down 6.5% Since Last Earnings Report: Can It Rebound?
-
Amgen (AMGN) Q4 Earnings Top, Horizon Drugs Drive Sales
-
Amgen (AMGN) Q4 Earnings and Revenues Top Estimates
-
Amgen: Q4 Earnings Snapshot
-
AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS
-
Amgen (AMGN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
-
Can Amgen (AMGN) Keep the Beat Streak Alive in Q4 Earnings?
-
Amgen (AMGN) Up 2.2% Since Last Earnings Report: Can It Continue?
-
Amgen (AMGN) Q3 Earnings Top Estimates
-
Amgen: Q3 Earnings Snapshot
-
AMGEN REPORTS THIRD QUARTER FINANCIAL RESULTS
-
Amgen (AMGN) to Report Q3 Earnings: Will It Beat Estimates?
-
Amgen (AMGN) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release